|

Allopurinol Clinical Trials

5 actively recruiting trials across 3 locations

▼ -1 trial since May 2026

Also known as: Aloprim, Zyloprim

Pipeline

Phase 2: 1Phase 3: 3Phase 4: 1

Top Sponsors

  • dr. M.J.N.L. Benders1
  • Massachusetts General Hospital1
  • M.D. Anderson Cancer Center1
  • Crystalys Therapeutics1
  • Alliance for Clinical Trials in Oncology1

Indications

  • Gout2
  • Arthritis2
  • Cancer2
  • Neuroprotection1
  • Congenital Heart Disease in Children1

Birmingham, Alabama2 trials

A Study of Dotinurad Versus Allopurinol in Participants With Gout

University of Alabama at Birmingham

Phase 3
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

University of Alabama at Birmingham Cancer Center

Phase 3

Other1 trial

Cerebrum and Cardiac Protection With Allopurinol in Neonates With Critical Congenital Heart Disease Requiring Cardiac Surgery With Cardiopulmonary Bypass
Phase 3

South Birmingham, Alabama1 trial

Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout

The University of Alabama at Birmingham

Phase 4

Houston, Texas1 trial

Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-naïve Chronic Lymphocytic Leukemia (CLL) or Richter Transformation (RT)

M D Anderson Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.